Exosect signs first formulation out-licence deal

Exosect out-licenses Entostat(R) enabled dual formulation for agrochemical sector

13th March 2017

Winchester, UK – Exosect Ltd., a pioneer in Lean Formulation Technology®, today announced that it has signed its first commercial agreement with a leading agrochemical company. The formulation, uses Exosect’s proprietary formulation platform Entostat®, to deliver a combination of two chemistries at significantly reduced rates, and has created a novel, proprietary insecticidal formulation for its partner.

Full press release here